Engineers Gate Manager LP Immunic, Inc. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $50,412 - $92,253	16,804 Added 123.2%	30,444 $96,000
Q2 2022 Aug 15, 2022	BUY	$3.13 - $12.25 $42,693 - $167,090	13,640 New	13,640 $47,000
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $110,940 - $165,829	-11,629 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.34 - $10.25 $172,100 - $240,331	-23,447 Reduced 66.85%	11,629 $111,000
Q3 2021 Nov 15, 2021	BUY	$8.05 - $13.29 $162,432 - $268,165	20,178 Added 135.44%	35,076 $310,000
Q2 2021 Aug 16, 2021	SELL	$11.76 - $16.85 $35,797 - $51,291	-3,044 Reduced 16.97%	14,898 $183,000
Q1 2021 May 17, 2021	BUY	$14.21 - $25.3 $254,955 - $453,932	17,942 New	17,942 $286,000

56.1M

4.7K

311K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $50.4M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.